Clinical Trial Update: Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab and oxaliplatin with irinotecan or leucovorin/fluorouracil for metastatic or recurrent colorectal cancer completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Irinotecan (Irinotecan)
• Leucovorin and Fluorouracil (leucovorin, fluorouracil)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-06-27